Skip to main content

Cutting Social Isolation, Loneliness May Lower Mortality in People With Obesity

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 24, 2024.

By Lori Solomon HealthDay Reporter

WEDNESDAY, Jan. 24, 2024 -- Improving social isolation and loneliness may attenuate excess obesity-related mortality risk, according to a study published online Jan. 22 in JAMA Network Open.

Jian Zhou, M.D., from the Tulane University School of Public Health and Tropical Medicine in New Orleans, and colleagues investigated whether improvement of social isolation or loneliness is associated with a lower obesity-related excess risk for mortality. The analysis included data from 398,972 participants in the U.K. Biobank with follow-up from March 2006 to November 2021.

The researchers found that compared with participants with obesity and an index of ≥2 for social isolation, risk for all-cause mortality was lower for participants with obesity and a social isolation index of 1 and 0. A similar trend was seen when comparing participants with obesity and a loneliness index of 1 and 0 with those with an index of 2 for loneliness. Risk for all-cause mortality decreased as the index of social isolation and loneliness went from highest to lowest in people with obesity versus people without obesity (hazard ratios decreased by 36 and 9 percent, respectively). Social isolation was ranked higher than loneliness, depression, anxiety, and lifestyle-related risk factors (e.g., alcohol, physical activity, and healthy diet) for estimating the risks for all-cause, cancer-related, and cardiovascular disease-related mortality.

"These findings support the improvement of social isolation and loneliness in people with obesity to decrease obesity-related excess risk of mortality," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million

TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...

High Social Media Use Tied to Depression in Only Some Teens

TUESDAY, July 2, 2024 -- High social media use is only tied to increased depression in teens who are already vulnerable, according to a study published online June 26 in...

Patient–Primary Care Provider Language Concordance Tied to Better Outcomes

TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.